Comparison of 68Ga-HBED-CCPSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology

被引:135
作者
Zamboglou, Constantinos [1 ,2 ]
Drendel, Vanessa [2 ,3 ]
Jilg, Cordula A. [2 ,4 ]
Rischke, Hans C. [1 ,2 ]
Beck, Teresa I. [2 ,5 ]
Schultze-Seemann, Wolfgang [2 ,4 ]
Krauss, Tobias [2 ,6 ]
Mix, Michael [2 ,5 ]
Schiller, Florian [2 ,5 ]
Wetterauer, Ulrich [2 ,4 ]
Werner, Martin [2 ,3 ]
Langer, Mathias [2 ]
Bock, Michael [2 ]
Meyer, Philipp T. [2 ,5 ]
Grosu, Anca L. [1 ,2 ]
机构
[1] Univ Freiburg, Fac Med, Med Ctr, Dept Radiat Oncol, Robert Koch Str 3, D-79106 Freiburg, Germany
[2] DKTK, German Canc Consortium, Partner Site Freiburg, Freiburg, Germany
[3] Univ Freiburg, Fac Med, Med Ctr, Dept Pathol, Freiburg, Germany
[4] Univ Freiburg, Fac Med, Med Ctr, Dept Urol, Freiburg, Germany
[5] Univ Freiburg, Fac Med, Med Ctr, Dept Nucl Med, Freiburg, Germany
[6] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol, Freiburg, Germany
来源
THERANOSTICS | 2017年 / 7卷 / 01期
关键词
Prostate cancer; PSMA PET/CT; multiparametric MRI; histopathology; MEMBRANE ANTIGEN; THERAPY; PET/CT; PSMA; ADENOCARCINOMA; TISSUES; BIOPSY;
D O I
10.7150/thno.16638
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: The exact detection and delineation of the intraprostatic tumour burden is crucial for treatment planning in primary prostate cancer (PCa). We compared Ga-68-HBED-CC-PSMA PET/CT with multiparametric MRI (mpMRI) for diagnosis and tumour delineation in patients with primary PCa based on slice by slice correlation with histopathological reference material. Methodology: Seven patients with histopathologically proven primary PCa underwent Ga-68-HBED-CC-PSMA PET/CT and MRI followed by radical prostatectomy. Resected prostates were scanned by ex-vivo CT in a special localizer and prepared for histopathology. Invasive PCa was delineated on a HE stained histologic tissue slide and matched to ex-vivo CT to obtain gross tumor volume (GTV-) histo. Ex-vivo CT including GTV-histo and MRI data were matched to in-vivo CT(PET). Consensus contours based on MRI (GTV-MRI), PSMA PET (GTV-PET) or the combination of both (GTV-union/-intersection) were created. In each in-vivo CT slice the prostate was separated into 4 equal segments and sensitivity and specificity for PSMA PET and mpMRI were assessed by comparison with histological reference material. Furthermore, the spatial overlap between GTV-histo and GTV-PET/-MRI and the Sorensen-Dice coefficient (DSC) were calculated. In the case of multifocal PCa (4/7 patients), SUV values (PSMA PET) and ADC-values (diffusion weighted MRI) were obtained for each lesion. Results: PSMA PET and mpMRI detected PCa in all patients. GTV-histo was detected in 225 of 340 segments (66.2%). Sensitivity and specificity for GTV-PET, GTV-MRI, GTV-union and GTV-intersection were 75% and 87%, 70% and 82%, 82% and 67%, 55% and 99%, respectively. GTV-histo had on average the highest overlap with GTV-union (57 +/- 22%), which was significantly higher than overlap with GTV-MRI (p=0.016) and GTV-PET (p=0.016), respectively. The mean DSC for GTV-union, GTV-PET and GTV-MRI was 0.51 (+/- 0.18), 0.45 (+/- 0.17) and 0.48 (+/- 0.19), respectively. In every patient with multifocal PCa there was one lesion which had both the highest SUV and the lowest ADC-value (mean and max). Conclusion: In a slice by slice analysis with histopathology, Ga-68-HBED-CC-PSMA PET/CT and mpMRI showed high sensitivity and specificity in detection of primary PCa. A combination of both methods performed even better in terms of sensitivity (GTV-union) and specificity (GTV-intersection). A moderate to good spatial overlap with GTV-histo was observed for PSMA PET/CT and mpMRI alone which was significantly improved by GTV-union. Further studies are warranted to analyse the impact of these preliminary findings for diagnostic (multimodal guided TRUS biopsy) and therapeutic (focal therapy) strategies in primary PCa.
引用
收藏
页码:228 / 237
页数:10
相关论文
共 33 条
  • [1] MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies
    Anastasiadis, Aristotelis G.
    Lichy, Matthias P.
    Nagele, Udo
    Kuczyk, Markus A.
    Merseburger, Axel S.
    Hennenlotter, Joerg
    Corvin, Stefan
    Sievert, Karl-Dietrich
    Claussen, Claus D.
    Stenzl, Arnulf
    Schlemmer, Heinz-Peter
    [J]. EUROPEAN UROLOGY, 2006, 50 (04) : 738 - 749
  • [2] [Anonymous], 2016, EUR UROL
  • [3] [Anonymous], [No title captured], DOI DOI 10.1016/J.EURURO.2013.05.048
  • [4] Boosting imaging defined dominant prostatic tumors: A systematic review
    Bauman, Glenn
    Haider, Masoom
    Van der Heide, Uulke A.
    Menard, Cynthia
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 274 - 281
  • [5] The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer
    Bott, Simon R. J.
    Ahmed, Hashim U.
    Hindley, Richard G.
    Abdul-Rahman, Ahmad
    Freeman, Alex
    Emberton, Mark
    [J]. BJU INTERNATIONAL, 2010, 106 (11) : 1607 - 1611
  • [6] Comparison of [11C] choline Positron Emission Tomography With T2-and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions
    Chang, Joe H.
    Joon, Daryl Lim
    Davis, Ian D.
    Lee, Sze Ting
    Hiew, Chee-Yan
    Esler, Stephen
    Gong, Sylvia J.
    Wada, Morikatsu
    Clouston, David
    O'Sullivan, Richard
    Goh, Yin P.
    Bolton, Damien
    Scott, Andrew M.
    Khoo, Vincent
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 438 - 445
  • [7] Prospective identification of tumorigenic prostate cancer stem cells
    Collins, AT
    Berry, PA
    Hyde, C
    Stower, MJ
    Maitland, NJ
    [J]. CANCER RESEARCH, 2005, 65 (23) : 10946 - 10951
  • [8] D'Amico A V, 1998, Semin Urol Oncol, V16, P153
  • [9] Novel Preclinical and Radiopharmaceutical Aspects of [Ga-68]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
    Eder, Matthias
    Neels, Oliver
    Mueller, Miriam
    Bauder-Wust, Ulrike
    Remde, Yvonne
    Schaefer, Martin
    Hennrich, Ute
    Eisenhut, Michael
    Afshar-Oromieh, Ali
    Haberkorn, Uwe
    Kopka, Klaus
    [J]. PHARMACEUTICALS, 2014, 7 (07): : 779 - 796
  • [10] 11C-Choline PET/pathology image coregistration in primary localized prostate cancer
    Grosu, Anca-Ligia
    Weirich, Gregor
    Wendl, Christina
    Prokic, Vesna
    Kirste, Simon
    Geinitz, Hans
    Souvatzoglou, Michael
    Gschwend, Juergen E.
    Schwaiger, Markus
    Molls, Michael
    Weber, Wolfgang A.
    Treiber, Uwe
    Krause, Bernd Joachim
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (12) : 2242 - 2248